Saturday, October 3, 2026

EUR/CHF Went Down By Over 1% In The Last 21 Sessions

ViaNews Editorial Team

February 21, 2023

EUR/CHF Went Down By Over 1% In The Last 21 Sessions

(VIANEWS) - EUR/CHF (EURCHF) has been up by 1.55% for the last 21 sessions. At 20:06 EST on Monday, 20 February, EUR/CHF (EURCHF) is $0.99.

EUR/CHF's yearly highs and lows, it's 4.592% up from its 52-week low and 6.201% down from its 52-week high.

Volatility

EUR/CHF's last week, last month's, and last quarter's current intraday variation average was a negative 0.29%, a negative 0.09%, and a positive 0.30%, respectively.

EUR/CHF's highest amplitude of average volatility was 0.44% (last week), 0.38% (last month), and 0.30% (last quarter), respectively.

News about

  • Usd/jpy consolidates in a narrow range, manages to hold above 134.00 mark. According to FXStreet on Monday, 20 February, "Against the backdrop of looming recession risks, geopolitical tensions drive some haven flows towards the Japanese Yen (JPY) and acts as a headwind for the USD/JPY pair. ", "This, in turn, will play a key role in influencing the USD/JPY pair and help determine the next leg of a directional move."
  • Usd/jpy prints mild gains above 134.00 as sour sentiment, fed concerns joins firmer yields. According to FXStreet on Monday, 20 February, "Looking forward, Japan's National Core Inflation numbers will join the second reading of the US fourth quarter (Q4) Gross Domestic Product to direct immediate USD/JPY moves. ", "USD/JPY pair's successful trading above the 200-day Exponential Moving Average (EMA), around 133.80 by the press time, keeps USD/JPY buyers to aim for December 2022 peak surrounding 138.20."
  • Hints of a change to boj's ultra-dovish monetary policy could see usd/jpy sell off again – ING. According to FXStreet on Monday, 20 February, "Hints of change to the BoJ's ultra-dovish monetary policy could pummel the USD/JPY pair, economists at ING r eport.", "Any hints of a change to the BoJ's ultra-dovish monetary policy could see USD/JPY sell off again - dragging the broader Dollar with it."
  • Usd/jpy price analysis: remains confined in a range around 134.00, bullish potential intact. According to FXStreet on Monday, 20 February, "Some follow-through buying beyond the monthly peak, around the 135.10 zone touched on Friday, should allow the USD/JPY pair to climb further towards the 135.55-135.60 horizontal zone and eventually aim to reclaim the 136.00 round-figure mark.", "The cautious market mood, amid looming recession risks and geopolitical tensions, underpins the safe-haven Japanese Yen (JPY) and acts as a headwind for the USD/JPY pair."

More news about EUR/CHF (EURCHF).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com